| abstract |
A solid pharmaceutical composition comprising sofosbuvir, one or more pharmaceutically acceptable excipients, and optionally at least one pharmaceutically acceptable matrix compound is provided and included in the solid pharmaceutical composition At least 99% by weight of sofosbuvir is present in amorphous form. The amorphous form of sofosbuvir is stable in solid pharmaceutical compositions. |